| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jan―26 |
Laboratory predictors of severe course and prognosis of chronic heart failure in patients after COVID-19 recovery |
A.P. Roytman, A.V. Bugrov, E.V. Ermolaeva, E.R. Matasova, P.A. Orlova, S.Ya. Tazina |
| 2 |
[GO] |
2024―Dec―28 |
Development and testing of the first domestic automatic cartridge-type POCT platform for the qualitative determination of SARS-CoV-2 RNA |
V.A. Ponomarev, V.G. Spudulite, E.V. Gorsky, Zh.E. Tarasova, D.A. Khodakov |
| 3 |
[GO] |
2024―Dec―28 |
Waiting for Disease X: a plan for preparing Russian laboratory services for the next pandemic |
G.A. Shipulin, A.M. Ivanov |
| 4 |
[GO] |
2024―Nov―25 |
Laboratory tests for diagnostics of cell immunity against SARS-CoV-2 (review of literature) |
P.I. Ivanova, A.V. Lobov, E.A. Pogodina, E.V. Sorokina, I.Zh. Shubina |
| 5 |
[GO] |
2024―Apr―04 |
Comparison of the clinical performance of immunochromatographic tests for the detection of SARS-CoV-2 antigens with data from independent studies |
K.T. Momynaliev, I.V. Ivanov |
| 6 |
[GO] |
2022―Nov―15 |
Gender and age features of the formation of a humoral immune response to COVID-19 vaccination |
V.V. Shustov, A.N. Tsibin, V.A. Gushchin, S.S. Petrikov, M.A. Godkov |
| 7 |
[GO] |
2022―May―17 |
Reducing Patient Risk and Enhancing Care Through the Development and Implementation of a New Chest Pain Pathway, Expedited by and for the COVID-19 Era |
M.P. Than, J.W. Pickering, P. Adamson, T. Clendon, C.M. Florkowski, J. Lainchbury, J. Loubser, A. Nankivel, S.J. Aldous |
| 8 |
[GO] |
2022―May―17 |
Homocysteine as a predictor of the severity of coronavirus infection: biochemical justification |
N.V. Vokhmianina, L.B. Gaikovaya, D.A. Evteeva, Yu.A. Vlasova |
| 9 |
[GO] |
2022―Jan―28 |
Unresolved issues of serological testing the new coronavirus infection COVID-19 |
N.A. Steriopolo |
| 10 |
[GO] |
2022―Jan―28 |
Clinical and pathogenetic significance of the determination of serum ferritin in coronavirus disease (COVID-19) |
Yu.I. Zhilenkova, N.Yu. Chernysh |
| 11 |
[GO] |
2022―Jan―28 |
Hematological Abnormalities in new coronavirus infection COVID-19 |
J.N. Filippova, T.G. Tsvetkova, E.V. Sinayskaya |
| 12 |
[GO] |
2022―Jan―28 |
Molecular mechanisms of hemostasis activation in COVID-19 at the hospital stage |
T.V. Vavilova, O.V. Sirotkina, A.I. Ermakov, Yu.I. Zhilenkova, L.B. Gaikovaya |
| 13 |
[GO] |
2022―Jan―28 |
Dynamics and gender and age features of the COVID-19 EPIDEMIC process in Moscow (results of screening survey for 1.5 years) |
M.A. Godkov, V.V. Shustov, E.A. Kasholkina |
| 14 |
[GO] |
2022―Jan―28 |
IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients |
S. Thompson, M.K. Bohn, N. Mancini, T. Loh, C. Wang, M. Grimmler, K. Yuen, R. Mueller, D. Koch, S. Sethi,, W. Rawlinson, M. Clementi,, R. Erasmus, M. Leportier, G. Kwon, M.E. Menezes, M. Patru, M. Gramegna, K. Singh, O. Najjar, M. Ferrari,, G. Lippi, K. Adeli,, A. Horvath |
| 15 |
[GO] |
2022―Jan―28 |
Molecular diagnostics of SARS-CoV-2, patient flow optimization in a multidisciplinary hospital |
A.V. Osipova, A.M. Danishevich, A.S. Chegodar’, N.A. Bodunova |
| 16 |
[GO] |
2022―Jan―28 |
Application of the Hypercube mathematical model for SARS-CoV-2 research |
N.A. Kolotyeva, O.A. Gusyakova, F.N. Gilmiyarova, I.Ye. Sinayskiy, N.A. Stadnitskaya, I.V. Gorbacheva, O.Yu. Kuznetsova, L.N. Vinogradova, O.S. Kuts |
| 17 |
[GO] |
2022―Jan―28 |
Foreign experience in molecular genetic and immunological diagnostics of SARS-CoV-2 (review) |
O.A. Perevesentsev, T.O. Cholodnaya, D.V. Burtsev |
| 18 |
[GO] |
2021―Oct―13 |
Determination of V617F mutation and JAK2 mRNA expression in venous blood of patients with COVID-19 |
I.A. Olkhovskiy, M.A. Stolyar, E.P. Tikhonova, A.S. Gorbenko, Yu.Yu. Komarovskiy, Yu.S. Kalinina, T.Yu. Kuzmina, V.I. Chernykh |
| 19 |
[GO] |
2021―Apr―09 |
Using the samples pools in SARS-COV-2 RNA virus testing by polymerase chain reaction |
I.A. Olkhovsky, V.A. Gushchin, N.A. Kuznetsova, O. V Rubalsky |
| 20 |
[GO] |
2020―Dec―29 |
Diagnostic performance of antibody tests for SARS-CoV-2 |
M.I. Prishchepa |
